Canada Pension Plan Investment Board’s Burning Rock Biotech BNR Stock Holding History

Canada Pension Plan Investment Board’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-123,800	Closed	-$11.8M	–	1332
2021 Q4	$11.8M	Hold	123,800	–	–	0.01%	540
2021 Q3	$22.1M	Hold	123,800	–	–	0.03%	444
2021 Q2	$36.5M	Hold	123,800	–	–	0.04%	344
2021 Q1	$33.3M	Hold	123,800	–	–	0.04%	335
2020 Q4	$28.6M	Buy	123,800 +38,800	+46%	+$10.4M	0.04%	302
2020 Q3	$21.3M	Hold	85,000	–	–	0.04%	268
2020 Q2	$23M	Buy	+85,000	New	+$23.3M	0.05%	239

Other funds holding BNR

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Canada Pension Plan Investment Board's BNR Position: Q1 2022 in Review

Canada Pension Plan Investment Board sold out of Burning Rock Biotech (BNR) in Q1 2022, closing a stake of 123,800 shares — an estimated $11.8M sold.

Canada Pension Plan Investment Board first reported a position in BNR in Q2 2020 and held it in 7 quarters. The position peaked at $36.5M in Q2 2021. 46 funds tracked by Wall St. Rank hold BNR as of Q1 2022.

Canada Pension Plan Investment Board reported no remaining Burning Rock Biotech position as of Q1 2022 after selling out during the quarter.
Canada Pension Plan Investment Board sold 123,800 Burning Rock Biotech shares in Q1 2022, an estimated $11.8M.
Canada Pension Plan Investment Board first reported a position in Burning Rock Biotech in Q2 2020 and held it in 7 quarters.
Canada Pension Plan Investment Board's Burning Rock Biotech position peaked at $36.5M in Q2 2021.
46 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2022.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2022, filed 13 May 2022.